期刊文献+

二甲双胍联用克罗米酚与腹腔镜下电凝术治疗多囊卵巢综合征合并不孕患者的疗效比较 被引量:2

A comparison of effects between metformin plus clomephene citrate and electrocoagulation therapy under laparoscope in patients with polycystic ovarian syndrome complicated with infertility
下载PDF
导出
摘要 目的:观察二甲双胍联用克罗米酚(CC)与腹腔镜下卵巢表面电凝术治疗多囊卵巢综合征(PCOS)合并不孕患者的疗效比较。方法:对确诊为胰岛素抵抗(IR)的48例PCOS合并不孕患者,随机分成两组:①双胍组(n=26):采用二甲双胍联用克罗米酚治疗;②电凝组(n=22),采用在腹腔镜下卵巢表面电凝术治疗。治疗前后采用免疫化学发光法检测黄体生成素(LH)、卵泡刺激素(FSH)、睾酮(T)、空腹血糖(FG)、空腹胰岛素(Fins),并观察月经、排卵和妊娠情况。结果:两组治疗后与治疗前比较:①LH、FSH、T、FG和Fins5项指标中,LH、T和Fins差异均非常显著(P<0.01);FSH和FG差异无显著性(P>0.05)。②两组治疗后排卵的例数与月经周期改善情况比较差异无显著性(P>0.05),但妊娠例数在电凝组显著高于双胍组(P<0.01)。结论:二甲双胍联用克罗米酚治疗PCOS能降低LH、T、Fins及改善月经周期,但较腹腔镜下卵巢表面电凝术治疗后妊娠率低。 Objective:To compare therapeutic effects between metformin plus clomephene citrate(CC) and electrocoagulation therapy under laparoscope in patients with polycystic ovarian sydrome(PCOS) complicated with infertility.Methods:Forty-eight PCOS with infertility divided into metformin group(n=26)with metformin plus CC and electrocoagulation group(n=22).Before and affer treatment,luteinizing hormone(LH),follicle-stimulating hormone(FSH),testosterone(T),fasting blood glucose(FG)and fasting insulin(Fins)were determined by immunochemiluminescence technique.Results:The levels of LH、T and Fins were significantly lower in both two groups(P<0.01),and pregnant rate in electrocoagulation group was obviously higher than that of metformin group(P<0.01).Conclusion:Metfomin plus CC could decline LH,T and Fins in PCOS with infertility and improve menses cycle,but pregnant rate with eletrocoagulation was significanthy higher than that with metformin.
出处 《中国妇幼保健》 CAS 北大核心 2005年第12期1461-1463,共3页 Maternal and Child Health Care of China
关键词 多囊卵巢综合征/诊断 高胰岛素血症 二甲双胍 克罗米酚 腹腔镜手术 电凝术 Polycystic ovarian syndrome/diagnosis Hyperinsulinemia Metformin Clomiphene citrate(CC) Laparoscope Electrocoagulation
  • 相关文献

参考文献8

  • 1Diamanti K E, Kouli C R, Bergiele A T et al. A Survey of the polycystic ovary syndrome in the Greek island of Lesbos. J Clin Endocrinol Metab, 1999, 84:4006~4011. 被引量:1
  • 2宋菊香,沈鸿敏.二甲双胍治疗多囊卵巢综合征的研究进展[J].中华妇产科杂志,2002,37(1):55-57. 被引量:28
  • 3Utiger RD. Insulin and the polycystic ovary syndrome. N Eng 1 J Med,1996, 335 (9): 657. 被引量:1
  • 4Velazquez E, Acosta A, Mendoza SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gyneal, 1997, 90(3) : 392. 被引量:1
  • 5Kocak M, Caliskam E, Simsir C et al. Metforme therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate resistant women with polycystic ovary syndrome. Fertil Steril, 2002, 77(1): 101~106. 被引量:1
  • 6Costello M F, Eden J A. A systematic review of the reproductive system effects of metform in in patients with polycystic ovary syn - drome. Fertil Steril, 2003, 79 (1): 1 ~ 13. 被引量:1
  • 7John EN, Daniela JJ, William SE et al. Effects of metform in on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome. N Engl J Med, 1998, 338 (26) : 1876. 被引量:1
  • 8任慕兰,赵维英,蔡云朗,何丽萍.腹腔镜卵巢电凝术治疗难治性多囊卵巢综合征的临床研究[J].中国微创外科杂志,2003,3(2):114-115. 被引量:22

二级参考文献14

  • 1la Marca A, Morgante G, Paglia T, et al. Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome. Fertil Steril, 1999,72:985-989. 被引量:1
  • 2Velazquez EM, Mendoza SG, Wang P, et al. Metformin therapy is associated with decrease in plasma plasminogen activator inhibitor-1,lipoprotein(a),and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism, 1997,46: 454-457. 被引量:1
  • 3Velazquez E, Acosta A, Mendoza SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol, 1997,90:392-395. 被引量:1
  • 4Glueck CJ, Wang P, Fontaine R,et al. Metformin-induced resumption of normal menses in 39 of 43(91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism, 1999,48:511-519. 被引量:1
  • 5Glueck CJ. Pregnancy failure and preservation in women with polycystic ovary syndrome: safety and efficacy of metformin therapy continued through pregnancy. Experimental Biology, 2000, (4): 16-18. 被引量:1
  • 6Acbay O, Gundogdu S. Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril, 1996, 65: 946-949. 被引量:1
  • 7Ehrmann DA, Cavaghan M,Imperial J,et al. Effects of metformin on insulin secretion, insulin action and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1997, 82:524-530. 被引量:1
  • 8Glueck CJ, Wang P, Fontaine RN,et al. Plasminogen activator inhibitor activity:an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism,1999,48:1589-1595. 被引量:1
  • 9Moghetti P, Castello R, Negri C, et al. Insulin infusion amplifies 17alpha-hydroxycorticosteroid intermediates response to adrenocorti cotropin in hyperandrogenic women: apparent relative impairment of 17, 20-lyase activity. J Clin Endocrinol Metab, 1996, 81: 881-886. 被引量:1
  • 10Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab, 2000, 85:139-146. 被引量:1

共引文献48

同被引文献23

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部